Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 2.7.11.24 extracted from

  • Shaw, D.; Wang, S.M.; Villasenor, A.G.; Tsing, S.; Walter, D.; Browner, M.F.; Barnett, J.; Kuglstatter, A.
    The crystal structure of JNK2 reveals conformational flexibility in the MAP kinase insert and indicates its involvement in the regulation of catalytic activity (2008), J. Mol. Biol., 383, 885-893.
    View publication on PubMed

Activating Compound

Activating Compound Comment Organism Structure
additional information phosphorylation at the activation loop residue Y185 by MKK4 activates JNK Homo sapiens

Cloned(Commentary)

Cloned (Comment) Organism
expression of wild-type and mutant enzymes with or without His6-tag in Escherichia coli strain BL21(DE3) Homo sapiens

Crystallization (Commentary)

Crystallization (Comment) Organism
purified recombinant His-tagged mutant enzyme in complex with inhibitor furan-2-carboxylic acid (3-[5-(4H-[1,2,4]triazol-3-yl)-1H-indazol-3-yl]-phenyl)-amide in 0.1 M MES, pH5.6, and 0.88 M sodium citrate, mixing of 0.001 ml of protein in 50 mM HEPES, pH 7.4, 100 mM NaCl, 10 mM MgCl2, 5% glycerol, 5 mM DTT, and 0.02% octyl-beta-D-glucopyranoside with 0.001 ml of 0.1 M MES, pH 5.6, 0.56-0.62 M sodium citrate, and 500 nl of 1000fold diluted seed stock, X-ray diffraction structure determination and analysis at 2.15 A resolution, molecular replacment and modelling Homo sapiens

Protein Variants

Protein Variants Comment Organism
C177S/C222S/K250A/K251A/K265A/K270A site-directed mutagenesis, the hexa-surfaced mutant forms crystallization complexes with inhibitor furan-2-carboxylic acid (3-[5-(4H-[1,2,4]triazol-3-yl)-1H-indazol-3-yl]-phenyl)-amide in contrast to other mutant variants or the wild-type enzyme Homo sapiens
D3K/C6V/S8N/14E site-directed mutagenesis using JNK2 1-362 or 1-364, the mutant does not crystallize Homo sapiens
K203A/E204A site-directed mutagenesis, the mutant does not crystallize Homo sapiens

Inhibitors

Inhibitors Comment Organism Structure
furan-2-carboxylic acid (3-[5-(4H-[1,2,4]triazol-3-yl)-1H-indazol-3-yl]-phenyl)-amide inhibits JNK2alpha2 enzyme in vitro Homo sapiens

Natural Substrates/ Products (Substrates)

Natural Substrates Organism Comment (Nat. Sub.) Natural Products Comment (Nat. Pro.) Rev. Reac.
additional information Homo sapiens JNK2 shows conformational flexibility in the MAP kinase insert and its involvement in the regulation of catalytic activity, the MAP kinase insert of JNK2 plays a role in the regulation of JNK2 activation, possibly by interacting with intracellular binding partners, overview ?
-
?

Organism

Organism UniProt Comment Textmining
Homo sapiens P45984 JNK2
-

Posttranslational Modification

Posttranslational Modification Comment Organism
phosphoprotein phosphorylation ate the activation loop residue Y185 by MKK4 activates JNK Homo sapiens

Purification (Commentary)

Purification (Comment) Organism
recombinant wild-type and mutant enzymes from Escherichia coli strain BL21(DE3) by anion exchange chromatography and gel filtration for non-tagged proteins, His6-tagged proteins are purified by nickel affinity chromatography Homo sapiens

Substrates and Products (Substrate)

Substrates Comment Substrates Organism Products Comment (Products) Rev. Reac.
additional information JNK2 shows conformational flexibility in the MAP kinase insert and its involvement in the regulation of catalytic activity, the MAP kinase insert of JNK2 plays a role in the regulation of JNK2 activation, possibly by interacting with intracellular binding partners, overview Homo sapiens ?
-
?

Subunits

Subunits Comment Organism
More structure analysis of JNK2, conformational flexibility of activation loop and loop 14 region, overview Homo sapiens

Synonyms

Synonyms Comment Organism
c-Jun N-terminal kinase 2
-
Homo sapiens
JNK 2
-
Homo sapiens

IC50 Value

IC50 Value IC50 Value Maximum Comment Organism Inhibitor Structure
0.00012
-
-
Homo sapiens furan-2-carboxylic acid (3-[5-(4H-[1,2,4]triazol-3-yl)-1H-indazol-3-yl]-phenyl)-amide